The nanoparticles can target tumors in vivo, inhibit tumor cell proliferation, promote tumor cell apoptosis, block PD1/PD-L1 signal binding between tumors and T cells, inhibit tumor immune escape, and promote T cell activation. This evidence concerns the gene CD274 and neoplasm.